These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7264958)

  • 1. Studies on the effect of antidepressants on kinetics and metabolism of tyramine.
    Faraj BA; Carrano RA; Ali FM; Malveaux EJ; Stacciarini WM
    J Pharmacol Exp Ther; 1981 Sep; 218(3):750-7. PubMed ID: 7264958
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to intravenous tyramine in man.
    Martini A; Bonollo L; Nicolis FB; Sega R; Palermo A; Braibanti E
    Br J Clin Pharmacol; 1981 Jun; 11(6):605-10. PubMed ID: 7272177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to oral tyramine in man.
    Martini A; Bonollo L; Nicolis FB; Sega R; Palermo A
    Br J Clin Pharmacol; 1981 Jun; 11(6):611-5. PubMed ID: 7272178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative pharmacological study of the antidepressants pyrazidol, inkazan, caroxazone and imipramine].
    Andreeva NI
    Farmakol Toksikol; 1982; 45(4):9-13. PubMed ID: 6889985
    [No Abstract]   [Full Text] [Related]  

  • 5. Levels of p-tyramine in rat brain after chronic administration of MAO-inhibiting antidepressants.
    Baker GB; Coutts RT; Legatt DF
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):779-82. PubMed ID: 6686709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical effects in vitro and in vivo of the antidepressant Ro 11-1163, a specific and short-acting MAO-A inhibitor.
    Da Prada M; Kettler R; Keller HH; Haefely WE
    Mod Probl Pharmacopsychiatry; 1983; 19():231-45. PubMed ID: 6865966
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers.
    Moretti A; Caccia C; Martini A; Bonollo L; Amico A; Sega R; Nicolella V; Nicolis FB
    Br J Clin Pharmacol; 1981 May; 11(5):511-5. PubMed ID: 7272163
    [No Abstract]   [Full Text] [Related]  

  • 8. The in vitro release of endogenous m-tyramine, p-tyramine and dopamine from rat striatum.
    Dyck LE; Juorio AV; Boulton AA
    Neurochem Res; 1982 Jun; 7(6):705-16. PubMed ID: 7121718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maze learning after the administration of antidepressant drugs.
    Latz A; Bain G; Goldman M; Kornetsky C
    J Pharmacol Exp Ther; 1967 Apr; 156(1):76-84. PubMed ID: 6023603
    [No Abstract]   [Full Text] [Related]  

  • 10. Swimming performance of mice as affected by antidepressant drugs and baseline levels.
    Latz A; Kornetsky C; Bain G; Goldman M
    Psychopharmacologia; 1966; 10(1):67-88. PubMed ID: 5982983
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of aromatic L-amino acid decarboxylase and tyrosine aminotransferase by the monoamine oxidase inhibitor phenelzine.
    Dyck LE; Dewar KM
    J Neurochem; 1986 Jun; 46(6):1899-903. PubMed ID: 2871132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological profile of a new non tricyclic antidepressant: oxaflozane (1,766 Cerm)].
    Hache J; Duchene-Marullaz P; Streichenberger G
    Therapie; 1974; 29(1):81-93. PubMed ID: 4849381
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of 3,4-dihydro-lH-1,4-oxazino[4,3-a] indoles, potential antidepressants, on biogenic amine uptake mechanisms and related activities.
    Lippmann W; Pugsley TA
    Arch Int Pharmacodyn Ther; 1977 Jun; 227(2):324-42. PubMed ID: 303083
    [No Abstract]   [Full Text] [Related]  

  • 14. Some basic aspects of reversible inhibitors of monoamine oxidase-A.
    Da Prada M; Kettler R; Burkard WP; Lorez HP; Haefely W
    Acta Psychiatr Scand Suppl; 1990; 360():7-12. PubMed ID: 2248079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade by triptyline compounds of tyramine uptake and of tyramine-induced phosphorylase activation in cardiac tissue.
    McNeill JH; Commarato MA
    Can J Physiol Pharmacol; 1969 Sep; 47(9):735-8. PubMed ID: 4898633
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the mechanism of action of caroxazone, a new antidepressant drug.
    Moretti A; Caccia C; Calderini G; Menozzi M; Amico A
    Biochem Pharmacol; 1981 Oct; 30(19):2728-31. PubMed ID: 6170295
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of the fate of tyramine in dogs: the effect of monoamine oxidase inhibition, portafemoral shunt and coronary artery ligation on the kinetics of tyramine.
    Faraj BA; Dayton PG; Camp VM; Wilson JP; Malveaux EF; Schlant RC
    J Pharmacol Exp Ther; 1977 Feb; 200(2):384-93. PubMed ID: 839443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarity between tyramine-induced neurotoxicity and the coma of Reye's syndrome.
    Faraj BA; Caplan DB; Malveaux EJ; Camp VM; Ali FM
    J Pharmacol Exp Ther; 1983 Aug; 226(2):608-15. PubMed ID: 6875868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyramine neurotoxicity and first-pass brain technetium-99m-diethylenetriamine penta-acetic acid.
    Faraj BA; Schmidt FH; Sarper R; Camp VM; Malveaux E
    J Pharmacol Exp Ther; 1987 Apr; 241(1):42-7. PubMed ID: 3553539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of the biochemical effects of beta-phenylethylhydrazine by deuterium substitution.
    Dyck LE; Durden DA; Yu PH; Davis BA; Boulton AA
    Biochem Pharmacol; 1983 May; 32(9):1519-22. PubMed ID: 6860370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.